好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Neuro Flash: Acute Stroke Management

Sunday 04/22/12
06:30 AM - 08:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Neuro Flash
Lawrence R. Wechsler, MD, FAAN
Participants should be familiar with emerging imaging strategies and state-of-the-art medical and interventional management of acute ischemic stroke.
No CME available
Patient Care & Procedural Skills
Trainee, General Neurologist, Specialist Neurologist
Case-based, Interactive, Audience Participation

Program Evaluations

Event Timeline
06:30 AM - 06:45 AM Case I—IV Thrombolysis 2012
Lawrence R. Wechsler, MD, FAAN
06:30 AM - 08:00 AM Break
06:45 AM - 07:00 AM Discussion
07:00 AM - 07:15 AM Case 2—IV/IA Thrombolysis: Is It Ready?
Lawrence R. Wechsler, MD, FAAN
07:15 AM - 07:30 AM Discussion
07:30 AM - 07:45 AM Case 3—Imaging Based Endovascular Therapy Beyond Conventional Time Windows
Tudor G. Jovin, MD
07:45 AM - 08:00 AM Discussion
Faculty Disclosures
Lawrence R. Wechsler, MD, FAAN Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Tudor G. Jovin, MD Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Jovin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Contego Medical. Dr. Jovin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Several law firms. Dr. Jovin has stock in Corindus. Dr. Jovin has stock in Methinks. Dr. Jovin has stock in Viz.ai. Dr. Jovin has stock in Route92. Dr. Jovin has stock in FreeOx Biotech. Dr. Jovin has stock in Galaxy. Dr. Jovin has stock in Kandu. The institution of Dr. Jovin has received research support from Stryker. The institution of Dr. Jovin has received research support from Medtronic.